UnitedHealth Group beat estimates on earnings per share last quarter, as it seeks to recover from significant declines in income this year.
Earnings per share were US$2.92, down from $7.15 year-over-year and above Zacks estimates of $2.75. Revenue was up 12% to $113.16 billion.
“We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter reflect solid execution toward that goal,” said UnitedHealth CEO Stephen Hemsley.
Consolidated earnings from operations were $4.32 billion, falling from $8.71 billion. Operating costs were $108.85 billion, up from $92.11 billion.
Revenue from premiums was $88.98 billion, growing from $77.44 billion. Products revenue was up to $13.30 billion, from $12.63 billion.
UnitedHealthcare’s revenue rose 16% to $87.1 billion, though its earnings from operations sank 57% to $1.8 billion. It served 50.1 million people in the United States last quarter, the company said, growing by 795,000.
Optum’s revenue increased 8% to $69.2 billion, driven by 16% growth in its Optum Rx pharmacy benefit management business. Earnings from operations dropped by 44% to $2.5 billion.
Its full-year outlook includes adjusted earnings per share of at least $16.25, above LSEG estimates of $16.20. UnitedHealth’s prior guidance expected at least $16.00 per share.
UnitedHealth Group’s (NYSE: UNH) share price is down 27.1% across 2025 to date. The company lost more than $250 billion in market capitalisation in April after reporting a major earnings miss and withdrawing its guidance, leading to the departure of CEO Andrew Witty.
The company has also reportedly been facing a U.S. Department of Justice investigation into potential Medicare fraud, which was opened in or before mid-2024.
Its share price closed at $367.84, up from its previous close at $365.98. Its market capitalisation is $333.14 billion.
Related content
